DEVICE · Unmapped registry intervention
Investigational Imaging device
Find medicine records ·
Find other trials using this name
Clinical trial
Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery
NCT03113825
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
AVB-620
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedStudy of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Carcinoma Breastunresolved
Breast Cancer Femaleunresolved
Carcinoma, Ductal, Breastunresolved
Stage II Breast Cancerunresolved
Stage I Breast Cancerunresolved
Stage III Breast Cancerunresolved
Interventions
AVB-620DRUG
Sponsors & collaborators
Avelas Biosciences, Inc.lead sponsor
RRD International, Inc.collaborator
Clinipace Worldwidecollaborator
Mapped research locations
SeattleWashington, United States1ClevelandOhio, United States1San DiegoCalifornia, United States1ColumbusOhio, United States1TampaFlorida, United States1Washington D.C.District of Columbia, United States1JacksonvilleFlorida, United States1Las VegasNevada, United States1CharlestonSouth Carolina, United States1The BronxNew York, United States1BuffaloNew York, United States1Royal OakMichigan, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03113825 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.